phase 2_completion
saveGastroenterological Association of Thailand — metadoxine (Phase II Trial Completion)
community read0 votes
Therapy area: Gastrointestinal. Indication: Metabolic and Alcohol-Associated Liver Disease (MetALD), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)